4.8 Article

NAIP-NLRC4-deficient mice are susceptible to shigellosis

期刊

ELIFE
卷 9, 期 -, 页码 -

出版社

ELIFE SCIENCES PUBLICATIONS LTD
DOI: 10.7554/eLife.59022

关键词

-

类别

资金

  1. Howard Hughes Medical Institute
  2. National Institutes of Health [AI064285, AI075039, AI063302, AI128743]
  3. Jane Coffin Childs Memorial Fund for Medical Research
  4. Irving H. Wiesenfeld CEND Fellow Graduate Student Fellowship
  5. UC Berkeley Department of Molecular and Cell Biology, NIH [5T32GM007232-42]
  6. Brit d'Arbeloff MGH Research Scholar
  7. Medical Research Foundation [MRF2012]

向作者/读者索取更多资源

Bacteria of the genus Shigella cause shigellosis, a severe gastrointestinal disease that is a major cause of diarrhea-associated mortality in humans. Mice are highly resistant to Shigella and the lack of a tractable physiological model of shigellosis has impeded our understanding of this important human disease. Here, we propose that the differential susceptibility of mice and humans to Shigella is due to mouse-specific activation of the NAIP-NLRC4 inflammasome. We find that NAIP-NLRC4-deficient mice are highly susceptible to oral Shigella infection and recapitulate the clinical features of human shigellosis. Although inflammasomes are generally thought to promote Shigella pathogenesis, we instead demonstrate that intestinal epithelial cell (IEC)-specific NAIP-NLRC4 activity is sufficient to protect mice from shigellosis. In addition to describing a new mouse model of shigellosis, our results suggest that the lack of an inflammasome response in IECs may help explain the susceptibility of humans to shigellosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据